13 Jun 2018 11:06
Sinclair Pharma plc
Result of AGM
13 June 2018, Sinclair Pharma plc (AIM: SPH.L), the international aesthetics company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.
For further information, please contact:
Sinclair Pharma plc Tel: +44 (0) 20 7467 6920
Chris Spooner
Alan Olby
Andy Crane
Peel Hunt LLP (NOMAD and Joint Broker) Tel: +44 (0) 20 7418 8900 James Steel
Oliver Jackson
RBC Capital Markets (Joint Broker) Tel: +44 (0) 20 7653 4000
Marcus Jackson
Media enquiries
FTI Consulting Tel: +44 (0) 20 3727 1000
Ben Atwell
Brett Pollard
Notes to Editors:
About Sinclair Pharma plc
Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, self-pay global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets, Brazil, South Korea and the US, and has a network of international distributors.